Public Health

Episodes 1-1 of 1

• 

  RestartResume

  FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents

  RestartResume

  FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents

  FDA Drug Information Updates

  FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents